Renal Cell Tumors More Likely To Metastasize Better Identified By Chemical Shift MRI
The study, conducted at Massachusetts General Hospital in Boston, included 156 patients with proven renal cell cancer. Clear cell renal carcinoma contains microscopic areas of fat, which is not seen on conventional imaging, said Dr. Azadeh Elmi, lead author of the study. "Chemical shift MRI enables us to quantify even small amounts of fat," she said. The study found that chemical shift MRI was about 83% accurate in differentiating clear cell renal cell carcinoma from other types of kidney cancer.
Clear cell type is the most common type of kidney cancer, and it has the greatest potential to metastasize, said Dr. Elmi. Chemical shift MRI is a protocol that can be readily performed in kidney MRI at no additional cost, she said. "As we are moving toward less invasive treatment strategies for cancer patients, the need to better distinguish tumor characteristics is becoming greater. This study demonstrates that chemical shift MRI is a promising tool in renal cell cancer characterization before planning treatment. The surgeons can get better insight of the tumor biology and can plan before hand," Dr. Elmi said.
The study was presented April 19 during the ARRS Annual Meeting in Washington, DC.
American Roentgen Ray Society
Source: EurekAlert!, the online, global news service operated by AAAS, the science society
Please use one of the following formats to cite this article in your essay, paper or report:
American Roentgen Ray Society. "Renal Cell Tumors More Likely To Metastasize Better Identified By Chemical Shift MRI." Medical News Today. MediLexicon, Intl., 22 Apr. 2013. Web.
24 May. 2017. <http://www.medicalnewstoday.com/releases/259427.php>
American Roentgen Ray Society. (2013, April 22). "Renal Cell Tumors More Likely To Metastasize Better Identified By Chemical Shift MRI." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.